You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
SharePoint
Sign In
Follow
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Home
About
CRISM​
OCRINT
National Executive Committee
Research Projects
OPTIMA
Lower Risk Cannabis Use Guidelines
Section 56 Consultation
Northern Ontario Drug Use and Service Needs Assessment (NODUS)
Implementation Science Program
Naloxone Distribution
Detoxification and Withdrawal Management
Corrections Project
Publications and Reports
Currently selected
Topic Summaries
Naloxone for Opioid Overdose
Prescription Opioids in Northern Ontario and First Nations
Supervised Consumption Facilities in Ontario
Drug Use in Ontario
News and Events
OCRINT Symposium
OCRINT Newsletters
Community Competition Grant
Become a Member
Inhalants
Page Content
6.1 Use
General Population
Youth and Young Adults
Special Populations
6.2 Interventions
Treatment
6.1 Use
General Population
There are no publicly available estimates of inhalant use for Ontario adults based on surveys representative of the adult population.
Youth and Young Adults
2.8% of Ontario students (grades 7-12) reported inhalant use in the past year. Rates have decreased from 3.4% in 2013 and were highest (6.2%) among students in grade 7 according to the 2015
OSDUHS
(n=10,426).
3
2% of Ontario high school students (grade 7-12) reported (past-year) glue, gasoline, solvent or salvia use to get high in the 2012-13
Youth Smoking S
urvey (Ontario sub-sample n=7,018).
94
Reported lifetime use rates were 1.0% for inhalants among Ontario postsecondary students, with 0.2% reporting past-month use, according to the 2013
NCHA Canadian survey
(Ontario sub-sample n=16,123).
6
Special Populations
Indigenous Populations
Less than 0.5% of (n=1,425) First Nations adults (aged 18+) used inhalants (past-year) according to the 2008-10
Regional Health Survey
representative of Ontario First Nation adults living on reserve.
8,9
Racialized Populations
There are no publicly available provincial data on inhalant use among racialized populations.
Homeless and Street-Involved Populations
3% of homeless adults in Toronto reported using inhalants (past two years)
among a stratified random sample
(n=1,191) in 2004-05.
12
Among Toronto-based homeless adults, 2% used solvents and other inhalants regularly (+3 times/week) in the past year,
based on a random sample
of (n=368) homeless adults in Toronto (2006-07).
11
One in five (20%) males and 13% of females reported popper use (past six months) among a convenience sample of (n=100) homeless youth (aged 16-24) who use substances surveyed in Toronto (
Drugs, Homelessness and Health survey
, 2008-09).
14
Pregnant and Parenting Women
There are no publicly-available provincial data on women's inhalant use during pregnancy.
Injection Drug Users
Solvent use among IDUs increased from 1.0% to 1.6% between 2006-08; less than 1.0% of participants reported inhalant use (past 6 months) among a convenience sample (n=1,643) (
Ontario Harm Reduction Distribution Program Evaluation
).
17
Recreational Drug Users
16% of Toronto 'recreational drug users' used poppers in the past year (2012-13
Health Canada High Risk Populations study
).
13
Almost a quarter (24.3%) of a s
ample of gay and bisexual men who used drugs
and attended gay dance clubs in Toronto reported using poppers "from time to time" among a convenience sample (n=74) in 2003.
83
6.2 Interventions
Treatment
0.3% (327 admissions) of patients presenting to Ontario publicly-funded substance abuse treatment reported glue and inhalants as a problem substance upon admission in 2012-13; a decrease of 50.2% (from 657 admissions) in 2007-08, according to data obtained from
DATIS
.
25